businesspress24.com - iRhythm Announces Upcoming Presentations of Zio(R) Patch Data at American College of Cardiology&#039
 

iRhythm Announces Upcoming Presentations of Zio(R) Patch Data at American College of Cardiology's Annual Scientific Session

ID: 1095438

Company to Exhibit at ACC.12 in Booth #3013

(firmenpresse) - SAN FRANCISCO, CA -- (Marketwire) -- 03/22/12 -- iRhythm Technologies, Inc., a medical device and service company that develops and markets simple, innovative diagnostic monitoring solutions, today announced two presentations at the upcoming American College of Cardiology's (ACC) 61st Annual Scientific Session in Chicago. One poster will present results from a study evaluating the use of iRhythm's Zio® Patch cardiac rhythm monitoring system in discharged emergency department patients with suspected arrhythmias, and the other will present data from a national registry of ambulatory ECG data from more than 25,000 patients wearing the Zio® Patch. The company will showcase its Zio® Patch ambulatory cardiac rhythm monitor at ACC.12 in the booth of its marketing partner, St. Jude Medical, Inc. (booth #3013).

The two poster presentations will take place during the ACC Moderated Poster Contributions Session "Monitoring Arrhythmia Patients: Externally, Via Implanted Devices and Wearable Defibrillators," on Monday, March 26 from 9:30 to 10:30 a.m. CT at McCormick Place South, Hall A.

Poster #1: Title: Prevalence of Arrhythmias in ED Patients Discharged Using a Novel Ambulatory Cardiac Monitor
Poster Board Number: 1245-509
Presenter: Ayesha Sattar, D.O., Clinical Instructor, Surgery- Emergency Medicine, Stanford University School of Medicine

Poster #2: Title: Clinical Experience and Diagnostic Yield from a National Registry of 14-Day Ambulatory ECG Patch Monitoring
Poster Board Number: 1245-513
Presenter: Mintu P. Turakhia, M.D., Director of Cardiac Electrophysiology, Palo Alto Veterans Affairs Health Care System, and Instructor of Medicine, Stanford University School of Medicine

iRhythm provides innovative and cost-effective diagnostic monitoring solutions that facilitate early diagnosis and treatment decisions, with the goal of ultimately improving patient health outcomes and reducing wasteful healthcare spending. Its flagship product, the Zio® Patch, is designed to optimize and simplify the diagnosis of cardiac arrhythmias. Zio® Patch is the smallest, lightest, least conspicuous cardiac arrhythmia diagnostic available and is indicated for up to 14-day monitoring. For more information, please visit .







Shelly Guyer
iRhythm Technologies, Inc.

415.632.5750

Jessica Volchok
WCG

310.774.3423


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  MELA Sciences Announces Agreement With Quintiles for Commercial Support Services for MelaFind(R) in Germany
ScinoPharm and National Health Research Institutes (NHRI) Announce Jointly Developed Diabetes Drug Approved for Phase I Clinical Trial
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 22.03.2012 - 07:00 Uhr
Sprache: Deutsch
News-ID 1095438
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

SAN FRANCISCO, CA


Phone:

Kategorie:

Medical Devices


Anmerkungen:


Diese Pressemitteilung wurde bisher 132 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"iRhythm Announces Upcoming Presentations of Zio(R) Patch Data at American College of Cardiology's Annual Scientific Session
"
steht unter der journalistisch-redaktionellen Verantwortung von

iRhythm (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von iRhythm



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 95


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.